Spero Therapeutics, Inc. (SPRO)
1.20
-0.02
(-1.64%)
USD |
NASDAQ |
Sep 01, 16:00
1.20
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Net Income (TTM) : 7.383M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.383M |
| March 31, 2026 | 15.24M |
| December 31, 2025 | 8.572M |
| September 30, 2025 | -43.84M |
| June 30, 2025 | -53.60M |
| March 31, 2025 | -69.76M |
| December 31, 2024 | -68.57M |
| September 30, 2024 | 3.514M |
| June 30, 2024 | 17.46M |
| March 31, 2024 | 23.40M |
| December 31, 2023 | 22.81M |
| September 30, 2023 | -1.614M |
| June 30, 2023 | -10.08M |
| March 31, 2023 | -26.85M |
| December 31, 2022 | -46.42M |
| September 30, 2022 | -102.43M |
| June 30, 2022 | -113.27M |
| Date | Value |
|---|---|
| March 31, 2022 | -103.16M |
| December 31, 2021 | -89.76M |
| September 30, 2021 | -79.10M |
| June 30, 2021 | -75.52M |
| March 31, 2021 | -74.44M |
| December 31, 2020 | -78.28M |
| September 30, 2020 | -84.68M |
| June 30, 2020 | -83.46M |
| March 31, 2020 | -79.11M |
| December 31, 2019 | -60.92M |
| September 30, 2019 | -46.54M |
| June 30, 2019 | -39.28M |
| March 31, 2019 | -36.09M |
| December 31, 2018 | -41.66M |
| September 30, 2018 | -44.93M |
| June 30, 2018 | -44.31M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | -67.43M |
| Fortress Biotech, Inc. | 141.19M |
| Kura Oncology, Inc. | -296.78M |
| Legend Biotech Corp. | -91.90M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |